Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

IMMU $2.20 0.3800 +20.88%
SCLN $8.76 0.6500 +8.01%
VBLT $3.39 0.2300 +7.28%
PVCT $0.52 0.0298 +6.11%
SNSS $0.79 0.0250 +3.29%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

KITE $41.47 -5.7200 -12.12%
OHRP $3.16 -0.3700 -10.48%
PBYI $39.72 -4.2600 -9.69%
CRIS $1.42 -0.1500 -9.55%
ATRA $17.16 -1.6800 -8.92%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

ACP Issues Advice For Evaluating Blood In The Urine As A Sign Of Cancer

(American College of Physicians) Jan 26, 2016 - In a paper published today in Annals of Internal Medicine, the American College of Physicians (ACP) issued High Value Care advice for the evaluation of blood in the urine, or hematuria, as a sign of urinary tract cancer and to help physicians make decisions about referral of patients for urological assessment.
read press release 



Abcodia Announces Expanded U.S. Availability of the ROCA® Test for Early Ovarian Cancer Detection

(Yahoo! Finance) Jan 26, 2016 - Abcodia, a commercial stage company focused on the development of proprietary tests for the early detection of cancer, today announced expanded U.S. availability of the ROCA® Test.
read article 



ImmunoGen Earns Milestone with Bayer's Initiation of a Phase 2 Clinical Study Designed to Support Anetumab Ravtansine Registration

(ImmunoGen) Jan 26, 2016 - ImmunoGen, Inc. today announced the Company earned a milestone payment with Bayer's initiation of a global Phase 2 clinical study designed to support registration of anetumab ravtansine (BAY 94-9343).
read corporate press release 



Phase I Trial Data for Cornerstone Pharmaceuticals' CPI-613 in Combination with Modified Fluorouracil, Leucovorin, Irinotecan, and Oxaliplatin (mFOLFIRINOX) in Metastatic Pancreatic Adenocarcinoma to Be Presented at ASCO GI

(Yahoo! Finance) Jan 25, 2016 - Cornerstone Pharmaceuticals, Inc. today announced that data from the Phase I clinical trial evaluating CPI-613 in combination with modified fluorouracil, leucovorin, irinotecan, and oxaliplatin (mFOLFIRINOX) to treat metastatic pancreatic adenocarcinoma was presented at the Annual Gastrointestinal Cancers Symposium, held by the American Society of Clinical Oncology (ASCO) in San Francisco, California on Friday, January 22, 2016.
read article 



Pilot Study Finds Smartphones May Decrease Sedentary Time, Increase Physical Activity

(American Cancer Society) Jan 25, 2016 - A pilot study finds that using smartphone reminders to prompt people to get moving may help reduce sedentary behavior.
read press release 



Scientists Synthesize Nanoparticles That Can Deliver Tumor Suppressors To Damaged Livers

(UT Southwestern) Jan 25, 2016 - UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.
read press release 



A Pen-Sized Microscope Could Spot Cancer in Your Doctor's Office

(Gizmodo) Jan 26, 2016 - The process of identifying cancer—from taking a sample of a tumor to getting the results back from a laboratory—can be long-winded. When there isn’t time for all that, this new hand-held microscope could help doctors identify cancer cells in just a few moments.
read article 



Weight May Influence Outcomes After Lung Cancer Surgery

(Drugs.com/HealthDay News) Jan 26, 2016 - Lung cancer surgery patients are most likely to have complications and to die if they're either too thin or fat, a new study suggests.
read article 



Afatinib Shows Clinical Benefit for Lung Cancer Patients with Brain Metastases

(IASLC) Jan 25, 2016 - Non-small cell lung cancer (NSCLC) patients with common epidermal growth factor (EGFR) mutations and brain metastases showed improved progression-free survival (PFS) and response from the EGFR tyrosine kinase inhibitor (TKI) afatinib compared to standard platinum doublet chemotherapy.
read press release 



Immune System Takes Long Time To Recover After Breast Cancer Chemo

(Medical News Today) Jan 26, 2016 - New research that looks at the long-term effects of chemotherapy on breast cancer survivors finds it weakens parts of the immune system for at least 9 months after treatment. This could leave patients with insufficient resilience to common infections, such as pneumonia and tetanus, even if they were immunized previously, say the researchers.
read article 



Targeted Axillary Dissection Of Lymph Nodes After Chemotherapy Improves Staging Accuracy Of Node-Positive Breast Cancer

(MD Anderson) Jan 25, 2016 - A new procedure developed by surgeons at The University of Texas MD Anderson Cancer Center improves the accuracy of axillary staging and pathologic evaluation in clinically node-positive breast cancer, and reduces the need for a more invasive procedure with debilitating complications.
read press release 



Little Benefit With Targeted Tx in GI Cancers

(MedPage Today) Jan 25, 2016 - Trials of Zaltrap and Kadcyla miss mark.
read article (free registration required) 



Put Off by Colonoscopy? Home Screening Test is Good Alternative, Study Shows

(KQED News/State of Health [No. California]) Jan 25, 2016 - An annual screening test for colon cancer that can be done at home showed strong effectiveness over several years, and patients who were sent the kits in the mail were very likely to participate year after year, a large study from Kaiser in both Northern and Southern California found.
read article 



Calls Intensify To Get Medicare To Pay For Genetic Sequencing Of Tumors

(STAT) Jan 26, 2016 - The Obama administration is facing growing calls to allow Medicare and Medicaid to pay for advanced gene-sequencing of tumors, a step proponents say will help both cancer patients and scientific research.
read article 



Shoddy Biopsies Deny Cancer Patients A Shot At Personalized Treatment

(STAT) Jan 22, 2016 - A huge federal trial of personalized cancer medicine has run into an unexpected roadblock: Many of the tumor samples aren’t robust enough to be put through genetic analysis.
read article 



Broad Institute Genomic Services Partners with Takeda Pharmaceuticals to Offer Genomic Insight Into The Recently Approved Therapeutic NINLARO® (ixazomib)

(TheStreet) Jan 22, 2016 - Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by the U.S. Food and Drug Administration (FDA), indicated in combination with lenalidomide and dexamethasone, for the treatment of patients with multiple myeloma who have received at least one prior therapy.
read article 



Deficiencies Found at Theranos Lab

(Wall Street Journal) Jan 24, 2016 - U.S. health inspectors have found serious deficiencies at Theranos Inc.’s laboratory in Northern California, according to people familiar with the matter.
read article (paid subscription required) 



Zika Virus Set To Spread Across Americas, Spurring Vaccine Hunt

(Reuters) Jan 25, 2016 - The mosquito-borne Zika virus, which has been linked to brain damage in thousands of babies in Brazil, is likely to spread to all countries in the Americas except for Canada and Chile, the World Health Organization said on Monday.
read article 



Drug Shortages In American ERs — Mostly Of Lifesaving Medicines To Treat Infectious Diseases Or Poisonings — Have Increased More Than 400 Percent

(Washington Post/To Your Health) Jan 22, 2016 - A new study published in the journal Academic Emergency Medicine shows that drug shortages in ERs across the United States increased by more than 400 percent between 2001 and 2014.
read article (free registration required) 



Fight To Lower Drug Prices Forces Some To Switch Medication

(NPR/Shots blog) Jan 25, 2016 - Oncologist Barbara McAneny, immediate past chairman of the American Medical Association, says very few chemotherapy drugs are excluded from approved drug lists. But the medications used to help patients get through chemo, like painkillers and hormone treatments, are. This complicates her ability to care for her patients.
read article 



CancerCare® Announces Funding for Multiple Myeloma Patients Through CancerCare Co-Payment Assistance Foundation (CCAF)

(CancerCare®) Jan 25, 2016 – CancerCare is pleased to announce the availability of co-payment assistance for people diagnosed with multiple myeloma through the CancerCare Co-Payment Assistance Foundation.
read press release 



ASCO Announces New Award Recognizing Extraordinary Contributions to Cancer Survivorship Care

(ASCO) Jan 22, 2016 - The American Society of Clinical Oncology (ASCO) today announced the creation of the Ellen L. Stovall Award and Lecture for Advancement of Cancer Survivorship Care, intended to recognize and promote the work of pioneers and leaders in the growing field of survivorship.
read press release 



Case Seeking Cancer Screenings for Smokers Heads to Trial

(ABC News/Associated Press) Jan 25, 2016 - A decade after a group of smokers from Massachusetts sued Philip Morris USA to try to force the cigarette maker to pay for lung cancer screenings, the case will finally be heard by a jury.
read article 



Cancer MoonShot 2020 Holds First Coalition Meeting: Inaugural Retreat of Thought Leaders from Government, Healthcare, Biotech, Scientific and Technology Communities Unify on Immediate Next Steps in the War on Cancer

(Yahoo! Finance) Jan 25, 2016 - Consensus reached on implementation of the Three Pillars of Cancer MoonShot 2020 Program: panomic, whole genomic and proteomic analysis; big data, predictive analytics, and interoperability; and a single platform to guide novel combination immunotherapeutic interventions of more than 20 immunotherapy combination protocols.
read article 



Are We Ready for a Blood Test for Cancer?

(UCSF) Jan 22, 2016 - Liquid biopsy shows promise, researchers say, but techniques still need more development.
read article